As of 2026-02-18, the Relative Valuation of Proteome Sciences PLC (PRM.L) is (28.83) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 GBP, the upside of Proteome Sciences PLC based on Relative Valuation is -1629.3%.
The range of the Relative Valuation is (19.11) - (28.87) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.9x - 35.3x | 34.3x |
| Forward P/E multiples | 22.2x - 33.6x | 32.8x |
| Fair Price | (19.11) - (28.87) | (28.83) |
| Upside | -1113.8% - -1631.6% | -1629.3% |
| Date | P/E |
| 2026-02-09 | -2.05 |
| 2026-02-06 | -2.14 |
| 2026-02-05 | -2.05 |
| 2026-02-04 | -2.11 |
| 2026-02-03 | -2.10 |
| 2026-02-02 | -2.19 |
| 2026-01-30 | -2.22 |
| 2026-01-29 | -2.34 |
| 2026-01-28 | -2.24 |
| 2026-01-27 | -2.31 |
| 2026-01-26 | -2.26 |
| 2026-01-23 | -3.84 |
| 2026-01-22 | -3.69 |
| 2026-01-21 | -3.51 |
| 2026-01-20 | -3.35 |
| 2026-01-19 | -4.13 |
| 2026-01-16 | -4.15 |
| 2026-01-15 | -4.09 |
| 2026-01-14 | -3.75 |
| 2026-01-13 | -3.81 |
| 2026-01-12 | -4.12 |
| 2026-01-09 | -3.80 |
| 2026-01-08 | -4.09 |
| 2026-01-07 | -4.05 |
| 2026-01-06 | -4.00 |
| 2026-01-05 | -3.19 |
| 2026-01-02 | -3.40 |
| 2025-12-31 | -2.93 |
| 2025-12-30 | -2.66 |
| 2025-12-29 | -2.67 |
| 2025-12-24 | -2.64 |
| 2025-12-23 | -2.66 |
| 2025-12-22 | -2.78 |
| 2025-12-19 | -2.70 |
| 2025-12-18 | -2.52 |
| 2025-12-17 | -2.77 |
| 2025-12-16 | -2.95 |
| 2025-12-15 | -2.67 |
| 2025-12-12 | -2.77 |
| 2025-12-11 | -2.75 |
| 2025-12-10 | -2.75 |
| 2025-12-09 | -2.82 |
| 2025-12-08 | -2.79 |
| 2025-12-05 | -3.11 |
| 2025-12-04 | -3.27 |
| 2025-12-03 | -2.63 |
| 2025-12-02 | -1.95 |
| 2025-12-01 | -1.96 |
| 2025-11-28 | -0.02 |
| 2025-11-27 | -0.02 |